Back to results
US 2012/0070410 A1Published application
Imidazolothiazole compounds and methods of use thereof
AssigneeAmbit Biosciences Corporation
InventorsJulius L. Apuy, Darren E. Insko, Joyce J. James
Life of this patent
Estimating the term…
Abstract
Compounds, compositions and methods are provided for modulating the activity of receptor kinases and for the treatment, prevention, or amelioration of one or more symptoms of disease or disorder mediated by receptor kinases.
Claims31
A compound of formula I:
- or a pharmaceutically acceptable salt, solvate, hydrate or prodrug thereof, wherein R1, R2 and R3 are selected as follows:
- i) R1 and R2 are each selected from —CH3, and —CH2OH;
- and R3 is selected from —CH3, —CH(OH)2, —CHO, —CH2OH,
- or
- ii) R1, R2 and R3 are each selected from —CH3 and —COOH;
- and
- R4 is selected from:
- with a proviso that the compound is not N-(5-tert-butyl-isoxazol-3-yl)-N′-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea.
5 more elements
The composition according to claim 8 further comprising a second therapeutic agent selected from a chemotherapeutic agent, an anti-proliferative agent, an anti-inflammatory agent, an immunomodulatory agent, an immunosuppressive agent or an anti-emetic agent.
Dependencies are inferred from the claim text.